目的：探讨达芬奇机器人手术行妇科手术的安全性、可行性及临床应用价值。方法：回顾性分析吉 林省肿瘤医院于 2014 年 10 月 ~2019 年 7 月完成的达芬奇机器人妇科手术患者 286 例的临床资料，其中恶性肿瘤 183 例，良性手术 103 例。恶性肿瘤中，99 例宫颈癌，82 例子宫内膜癌，1 例卵巢癌，1 例阴道癌。评估所有患者 的临床指标，包括手术时间、术中失血量、术后肠道功能恢复时间、膀胱功能恢复时间、腹部切口愈合时间；分析 恶性肿瘤患者的淋巴结切除数目、术后并发症发生情况（出血、感染、尿潴留、肠梗阻、下肢深静脉血栓等）、总 住院时间等；通过检测所有手术患者血清 C 反应蛋白（CRP）和白介素 -6（IL-6）浓度的变化判断手术对机体炎 症反应的影响。结果：286 例患者手术均顺利完成，无中转开腹，无术中大出血、脏器损伤等严重并发症。手术时 间 34~280min，平均（148.7±97.8）min；出血量 0~170ml，平均（83±69）ml；术后肠道功能恢复时间为 6~68h， 平均（35.3±19.6）h；膀胱功能恢复时间 10~504h；术后 72h 引流量 9~376ml，平均（198.3±79.4）ml；引流管留 置时间 49~296h，平均（187.9±74.8）h；术后腹部切口拆线 78~128h，平均（96.3±10.6）h；恶性肿瘤切除淋巴结 切除数目 7~46 枚，平均（33.4±7.3）枚；住院时间 85~678h，平均（304.5±107.3）h。术后感染发生 6 例，肠梗阻 5 例，血栓性并发症 4 例，1 例单侧小腿肌间静脉血栓，1 例左侧腘静脉血栓，1 例 PICC 置管处头静脉血栓性静脉 炎，1 例术后 5 个月（放化疗）出现右小腿肌间静脉血栓，经溶栓、抗凝治疗好转；术后发生淋巴囊肿 24 例，其中 14 例出现不同程度的外阴水肿，经对症处置后均恢复良好。于术后 24h 测定 C 反应蛋白浓度为 39.8~220.3mg/L，平 均（109.47±38.79）mg/L；术后 5d 浓度为 4.7~21.4mg/L，平均（19.58±5.63）mg/L。术后 24h 测定白介素 -6 浓度为 10.2~18.9ng/L，平均（14.57±3.94）ng/L；术后 5d 浓度为 3.7~12.4ng/L，平均（6.51±2.74）ng/L。结论：达芬奇机器 人应用于妇科手术安全可行，值得临床推广应用。

    Objective: To investigate the safety, feasibility and clinical application value of Da Vinci surgical system in gynecological surgery. Methods: The clinical data of 286 patients underwent Da Vinci robotic surgery in Jilin Province Cancer Hospital from October 2014 to July 2019 was retrospectively analyzed. Results: All the surgeries were successfully completed without conversion to open surgery, no massive hemorrhage or organ damage was found. The operation time was 34min to 280min, the mean operation time was (148.7±97.8) min. The bleeding volume was 0 ml to 170ml, with mean bleeding volume of (83±69) ml. The recovery time of intestinal function after surgery was 6h to 68h, with average recovery time of (35.3±19.6) h. The recovery time of bladder function was 10h to 504h. The volume of drainage was 9ml to 376ml 72 hours after surgery, with average volume of (198.3± 79.4) ml. The drainage tube indwelling time was 49h to 296h, with mean time of (187.9±74.8) h. Stitch removing time of abdominal incision was 78h to 128h, with an average time of (96.3±10.6) h. The number of lymph node resections for malignant tumor resection was 7 to 46, with an average of (33.4±7.3). Hospital stay was 85h to 678h, with an average of (304.5±107.3) h. 6 cases of postoperative infection, 5 cases of intestinal obstruction, 4 cases of thrombotic complications, 1 case of unilateral calf intermuscular venous thrombosis, 1 case of left iliac vein thrombosis, and 1 case of venous thrombosis of PICC catheter were found. 1 case of thrombophlebitis caused by PICC tube dwelling. 1 cases of venous thrombosis on the right calf muscle 5 months after chemoradiotherapy, which improved after thrombolysis and anticoagulation. 24 cases of postoperative lymphadenopathy were found, among which 14 cases of vulval edema in different degrees happened and all recovered well after symptomatic treatment. In the above cases, the C-reactive protein concentration was measured at 39.8mg/L to 220.3mg/L 24 hours after surgery, with an average of (109.47±38.79) mg/L. The concentration was 4.7mg/L to 21.4mg/L 5 days after surgery, with an average of (19.58±5.63) mg/L. The concentration of interleukin-6 was determined to be 10.2ng/L to 18.9ng/L 24 hours after surgery, with an average of (14.57±3.94) ng/L. The concentration was 3.7ng/L to 12.4ng/L 5 days after operation, with an average of (6.51±2.74) ng/L. Conclusion: Da Vinci surgical system is safe and feasible for gynecological surgery, which is worthy to be promoted for clinical application. 

收稿日期：2020-08-05  录用日期：2020-11-03 

Received Date: 2020-08-05  Accepted Date: 2020-11-03 

基金项目：吉林省科技发展计划项目（20190303179SF） 

Foundation Item: Science and Technology Development Plan Project of Jilin Province (20190303179SF) 

通讯作者：袁勇，Email：99448409@qq.com 

Corresponding Author: YUAN Yong, Email:  99448409@qq.com 

引用格式：齐金红，袁勇，冯文娟，等 . 达芬奇机器人在妇科手术应用中的安全性评价 [J]. 机器人外科学杂志，2021，2（2）： 111-122. 

Citation: QI J H, YUAN Y, FENG W J, et al. Safety evaluation on Da Vinci surgical system in gynecological surgery[J]. Chinese Journal of Robotic Surgery,  2021, 2(2):111-122.

[1] Louis G, Huber K, Ladriere M, et al. Roboticassisted laparoscopicdonor nephrectomy for kidney transplantation. An evaluation of 35 proedures[J]. Nephrologie & Theraeutique, 2009, 5(7): 623-630.  

[2] 孟元光 , 翟青枝 . 达芬奇机器人系统在妇科领域的 应用进展及展望 [J]. 妇产与遗传 ( 电子版 ), 2019, 6(9): 10-13. 

[3] 刘忠秀 , 李秀丽 , 李卫平 . 达芬奇机器人手术系 统在妇科肿瘤的临床应用 [J]. 中华腔镜外科杂志 , 2014, 12(7): 491-494. 

[4] 丁晓萍 , 刘蕊 , 刘媛媛 . 达芬奇机器人辅助卵巢子 宫内膜异位囊肿手术 8 例临床分析 [J]. 中国妇产科 临床杂志 , 2010, 11(6): 447-448. 

[5] Dia z-Arrastie C, Jumalov C, Gomez G, et al. Laparoscopic hysterectomy using a computer- enhanced surgical robot[J]. Surg Endose, 2002, 16(9): 1271-1273. 

[6] Payne T N, Dauterive L. A comparison of total laparoscop-ic hysterectomy to robotically assisted hysterectomy: surgical outcomes in a community practice[J]. J Minim Invasive Gynecol, 2008, 15(3): 286-291. 

[7] Vlaovic P D, Sargent E R, Boker J R, et al. Immediate impact of an intensive one week laparoscopy training program on laparoscopic skills among postgraduate urologists [J]. JSLS, 2008, 12(1): 1-8. 

[8] 姚元庆 . 机器人妇科肿瘤手术的现状和展望 [J]. 中 华腔镜外科杂志 ( 电子版 ), 2013, 10(6): 330-333. 

[9] Vercellini P, Frattaruolo M P, Rosati R, et al. Medical or treatment surgery for colorectal endometriosis? Results of a shared decision-making approach[J]. Hum Reprod, 2018, 33(2): 202-211.

[10] Ugwumadu L, Chakrabarti R, Williams-Brown E, et al. The role of the multidisciplinary team in the management of deep infiltrating endometriosis[J]. Gynecol Surg, 2017, 14(1): 15. 

[11] Alkatout I, Meinhold-Heerlein I, Keckstein J, et al. Endometriosis: A concise practical guide to current diagnosis and treatment[J]. J Turk Ger Gynecol Assoc, 2018, 19(3): 173-175. 

[12] McGuire S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015[J]. Adv Nutr, 2016, 7(2): 418-419. 

[13] 王皓洁 , 范颖 , 李斌 . 保留生育功能的宫颈癌手术 及术后妊娠分析 [J]. 中华临床医师杂志 ( 电子版 ), 2015, 1(9): 26-29 

[14] Park J Y, Kim D Y, Suh D S, et al. Reproductive outcomes after laparoscopic radical trachelectomy for early-stage cervical cancer[J]. J Gynecol Oncol, 2014, 25(1): 9-13. 

[15] Rob L, Pluta M, Skapa P, et al. Advances in fertilitysparing surgery for cervical cancer[J]. Expert Rev Anticancer Ther, 2010, 10(7): 1101-1114. 

[16] 王留利 , 闫沛静 , 杨克虎 . 机器人与腹腔镜手术治 疗妇科疾病围术期效果对比分析 [J]. 中华腔镜外科 杂志 ( 电子版 ), 2018, 12(11): 347-351. 

[17] Ramirez P T, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J]. New Engl J Med, 2018, 379(20): 1895-1904. 

[18] Melamed A, Margul D J, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer[J]. New Engl J Med, 2018, 379(20): 1905-1914. 

[19] 中华医学会妇科肿瘤学分会 . 宫颈癌微创手术的中 国专家共识 [J]. 现代妇产科进展 , 2019, 11(28): 801- 803. 

[20] LIANG Z, CHEN Y, XU H, et al．Laparoscopic nerve-sparing radical hysterectomy with fascia space dissection technique for cervical cancer: Description of technique and outcomes[J]. Gynecologic Oncology, 2010, 119(2): 202-207. 

[21] Kang S, Yoo H J, Hwang J H, et al. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies[J]. Gynecol Oncol, 2011, 123(3): 522-527. 

[22] 张师前 , 董延磊 . 腹腔镜在卵巢癌诊治中需要重视 的问题商榷 [J]. 中华腔镜外科杂志 ( 电子版 ), 2018, 4(11): 77- 79. 

[23] Lamblin G, Meysonnier C, Moret S, et al. Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition[J]. Int Urogynecol J, 2018, 29(5): 715-721. 

[24] Ceccaroni M, Roviglione G, Bruni F, et al. Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. “The times they are a-changin”?[J]. Surg Endosc, 2018, 32(4): 2026-2037. 

[25] SHENG X, ZHONG Y, LU C, et al. Clinical study of hereditary ovarian cancer syndrome in Shandong province, East China[J]. Int J Gynaecol Obstet, 2018, 141(2): 234-239. 

[26] Lamblin G, Thiberville G, Bansac Lamblin A, et al. What haemostatic technique should we use for opportunistic salpingectomy during benign laparoscopic hysterectomy?[J]. Gynecol Obstet Fertil Senol, 2017, 45(9): 453-459. [27] Segaert A, Traen K, Van Trappen P, et al. Robotassiterd radical hysterectomy in cervical carcinoma: the belgain experience[J]. International Journal of Gynecological Cancer, 2015, 25(9): 1690-1696. 

[28] 孙小单 , 袁勇．机器人及传统腹腔镜全子宫切除术 的临床比较 [J]. 中华腔镜外科杂志 ( 电子版 ), 2015, 8(2): 103-106. 

[29] MacLellan S J, MacKay H J, Ringash J, et al. Laparoscopic gastrectomy for patients with advanced gastric cancer produces oncologic outcomes similar to those for open resection[J]. Surg Endosc, 2012, 26(7): 1813-1821. 

[30] 杜斌 , 李毅 , 陈德昌 . 血清降钙素原和白细胞介素 6 检测感染和非感染性全身性炎症反应鉴别诊断中 的应用 [J]. 中华医学杂志 , 2002, 8(16): 1111-1114. 

[31] Fehm T, Solomayer E F, Meng S, et al. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells[J]. Cytotherapy, 2005, 7(2): 171-185. 

[32] Sinno A K, Fader A N. Robotic-assisted surgery in gynecologic oncology[J]. Fertil Steril, 2014, 102(4): 922-932. 

[33] Orady M, Hrynewych A, Nawfal A K, et al. Comparison of robotic assisted hysterectomy to other minimally invasive approaches[J]. JSLS, 2012, 16(4): 542-548.